18F-alfatide PET/CT may predict the survival of patients with stage II-IV lung cancer

Conclusions: The SUVLN on 18F-alfatide PET/CT may be the preferred parameter for predicting the survival of lung cancer.

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Wei, Y., Qin, X., Luan, X., Zhou, Y., Yuan, S., Yu, J. Tags: Lung Cancer (Poster Session) Source Type: research